DLH (NASDAQ:DLHC - Get Free Report) will likely be issuing its Q2 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $58.00 million for the quarter. Parties may visit the the company's upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, May 7, 2026 at 10:00 AM ET.
DLH (NASDAQ:DLHC - Get Free Report) last posted its earnings results on Monday, February 9th. The business services provider reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.07) by ($0.02). DLH had a negative return on equity of 0.95% and a negative net margin of 0.33%.The business had revenue of $68.89 million during the quarter, compared to analyst estimates of $70.15 million. On average, analysts expect DLH to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
DLH Trading Down 2.2%
Shares of DLHC stock opened at $5.85 on Wednesday. DLH has a 52-week low of $3.53 and a 52-week high of $8.10. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.97 and a current ratio of 0.97. The company has a 50-day simple moving average of $5.86 and a two-hundred day simple moving average of $5.83. The company has a market capitalization of $84.77 million, a price-to-earnings ratio of -83.56 and a beta of 1.57.
Analyst Ratings Changes
A number of brokerages have issued reports on DLHC. Weiss Ratings reaffirmed a "sell (d)" rating on shares of DLH in a research report on Monday, April 20th. Zacks Research raised shares of DLH from a "strong sell" rating to a "hold" rating in a research report on Monday, April 13th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Reduce".
Get Our Latest Report on DLHC
Insider Buying and Selling at DLH
In related news, major shareholder Mink Brook Asset Management Ll bought 22,057 shares of DLH stock in a transaction dated Wednesday, February 18th. The stock was purchased at an average cost of $5.50 per share, with a total value of $121,313.50. Following the transaction, the insider directly owned 1,975,147 shares of the company's stock, valued at approximately $10,863,308.50. The trade was a 1.13% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last ninety days, insiders have purchased 46,839 shares of company stock worth $257,615. 12.80% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of DLHC. Jane Street Group LLC bought a new position in shares of DLH during the 4th quarter valued at approximately $58,000. Bank of America Corp DE grew its position in shares of DLH by 31.9% during the 4th quarter. Bank of America Corp DE now owns 7,679 shares of the business services provider's stock valued at $62,000 after acquiring an additional 1,855 shares during the period. Qube Research & Technologies Ltd bought a new position in shares of DLH during the 2nd quarter valued at approximately $73,000. Strs Ohio bought a new position in shares of DLH during the 1st quarter valued at approximately $185,000. Finally, Sandia Investment Management LP bought a new position in shares of DLH during the 4th quarter valued at approximately $197,000. 67.25% of the stock is owned by institutional investors.
DLH Company Profile
(
Get Free Report)
DLH Holdings Corp. NASDAQ: DLHC is a provider of mission-driven professional services primarily to federal government agencies and select commercial clients. The company designs and delivers tailored solutions across a range of critical mission areas, including program and project management, consulting, technical assistance, and administrative support. Through its Healthcare Solutions offerings, DLH also specializes in supporting clinical and allied health staffing needs for federal health agencies and health systems.
Operating under its Federal Solutions segment, DLH partners with agencies such as the Department of Veterans Affairs, Department of Defense, Department of Homeland Security, and the Department of Health and Human Services.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DLH, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DLH wasn't on the list.
While DLH currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.